2024 |
Charles River Laboratories International Inc.
|
Independent Director |
- |
- |
2024 |
Regeneron Pharmaceuticals, Inc.
|
Independent Director |
- |
- |
2023 |
Charles River Laboratories International Inc.
|
Independent Director |
437.8 K |
- |
2023 |
Regeneron Pharmaceuticals, Inc.
|
Independent Director |
247.8 K |
-75.8 % |
2022 |
Regeneron Pharmaceuticals, Inc.
|
Independent Director |
1.0 M |
- |
2022 |
Charles River Laboratories International Inc.
|
Director |
- |
- |
2018 |
Merck & Co Inc
|
- |
286.3 K |
-4.6 % |
2018 |
Charles River Laboratories International Inc.
|
- |
285.0 K |
-0.0 % |
2018 |
Charles River Laboratories International Inc.
|
Independent Director |
- |
- |
2018 |
Merck & Co Inc
|
Independent Director |
- |
- |
2017 |
Merck & Co Inc
|
Independent Director |
300 K |
0.0 % |
2017 |
Charles River Laboratories International Inc.
|
Independent Director |
285.1 K |
12.2 % |
2016 |
Merck & Co Inc
|
Independent Director |
300 K |
13.2 % |
2016 |
Charles River Laboratories International Inc.
|
Independent Director |
254.0 K |
-0.3 % |
2015 |
Merck & Co Inc
|
Independent Director |
265 K |
0.0 % |
2015 |
Charles River Laboratories International Inc.
|
Independent Director |
254.7 K |
-53.2 % |
2014 |
Charles River Laboratories International Inc.
|
Independent Director |
544.3 K |
- |
2014 |
Merck & Co Inc
|
Independent Director |
265 K |
0.0 % |
2013 |
Merck & Co Inc
|
Independent Director |
265 K |
1.9 % |
2013 |
Charles River Laboratories International Inc.
|
Independent Director |
- |
- |
2012 |
Merck & Co Inc
|
Independent Director |
260 K |
4.0 % |
2011 |
Merck & Co Inc
|
Independent Director |
250 K |
46.4 % |
2010 |
Merck & Co Inc
|
Independent Director |
170.8 K |
-38.6 % |
2009 |
Merck & Co Inc
|
Director |
278.1 K |
- |